Faster approval process for innovative drugs
Drug regulators will speed up approvals for innovative drugs for major diseases as well as those on the list of theNational Science and Technology Research Program, according to the 28th ChinaMedicine Industry Development Summit Forum. In the next fewyears, the pharmaceutical industry’s growth will likely slow to around 10 percent. But, demand for drugs won’t slow, experts said. So, faster approvals and pro-industry policies can help make innovative medicine the main investment area in medicine, they said.